Krebsbio
Live Price
Recent news and updates for KREBSBIO will appear here soon.
"Caution advised for KREBSBIO investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.
As of the latest market session, Krebsbio (KREBSBIO) is trading at ₹55.79, representing a move of 3.99% from the previous close.
Krebsbio is listed and traded under the ticker symbol KREBSBIO on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Krebsbio's stock price moved by 3.99%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 10% bullish probability for KREBSBIO stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Krebsbio shares reached a high of ₹82.49 and hit a low of ₹38.33.
KREBSBIO exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 10,136 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Krebsbio has a market capitalization of ₹120.29 Cr, designating its size class inside the Healthcare sector.
Krebsbio has a current dividend yield of N/A. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Krebsbio's trailing Price-to-Earnings (P/E) ratio is —. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Krebsbio (KREBSBIO) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Krebsbio's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore KREBSBIO's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for KREBSBIO are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Krebsbio operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.